Moderna signals beyond the news: 57+ signals from 6 sources
The latest Moderna signal on this page is from Sep 29, 2026 (Patents): "ModernaTX, Inc.'s patent output is steady: 24 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (15+) and YouTube (11).
Public (MRNA)Biotechnology Research5,001 to 10,000 employeesmodernatx.comLinkedIn
- Signals
- 57+
- Sources
- 6
- Last 90 days
- 30
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Moderna signals by source
57+ signals for Moderna across 6 sources.
Patents · Patent pace
ModernaTX, Inc.'s patent output is steady: 24 grants in the past year, 2 in the past 30 days.
Over the past year ModernaTX, Inc. received 24 US patent grants; the recent pace (4 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 24
- Grants, 90 days
- 4
- Grants, 30 days
- 2
- USPTO assignee
- ModernaTX, Inc.
Patents · Patent counsel
ModernaTX, Inc. uses Clark & Elbing LLP as outside IP counsel.
Clark & Elbing LLP is the attorney of record on ModernaTX, Inc.'s recent US patent work, including a grant in 2026-09.
- Law firm
- Clark & Elbing LLP
- Law firm domain
- clarkelbing.com
- Matter date
- Sep 22, 2026
Glassdoor · Consistent leadership complaints
Inexperienced and toxic management contributes to mercenary culture and political issues
One reviewer states the company has inexperienced management and toxic politics leading to a mercenary culture, while another mentions disorganized leadership and disparity in recognition between teams.
- Overall rating
- 3.3 of 5
- CEO approval
- 47%
- Reviews read
- 8
- Review window
- Aug 13, 2026 to Aug 31, 2026
Glassdoor · Strategic direction unclear
Employees report frequent changes in company direction without clear strategy
Multiple reviews mention the organization changes direction frequently, with a lack of clear thought or methodology behind these pivots in the young, growing company.
- Overall rating
- 3.3 of 5
- CEO approval
- 47%
- Reviews read
- 8
- Review window
- Aug 13, 2026 to Aug 31, 2026
Website changes · Geographic expansion
Moderna added webcast and press-release materials for its Q2 2026 conference call, Science Day, Goldman Sachs conference, and investor-relations filings.
New entries include “Moderna Second Quarter 2026 Conference Call” on July 31, “Moderna Science Day” on June 25, “Goldman Sachs 47th Annual Global Healthcare Conference 2026” on June 9, and a “Press Release” and “Filing” link.
- Page
- /
Website changes · Funding news
Moderna’s investor-relations website now reports quarterly results of $174.38 per share and 199.25 million dollars in volume.
The page changed from “NASDAQ: MRNA $0.00 VOL: $0.00” to “NASDAQ: MRNA $174.38 VOL: 199.25M.”
- Page
- /
YouTube
Moderna favors rich, issues vaccines for profit.
Video alleges Moderna prioritizes profit over equitable vaccine distribution to the rich.
- Channel
- Mercedes Livingston
- Views
- 1
- Comments
- 0
- Tags
- Criticism, Vaccine Distribution
YouTube
Moderna's Hantavirus Vaccine Development
Moderna and Korea University are developing an mRNA vaccine for hantavirus.
- Channel
- The AI Opus
- Views
- 0
- Comments
- 0
- Tags
- Vaccine Development, Biotechnology, Partnership
Web traffic · Sustained decline
modernatx.com shows sustained decline with 3 consecutive months of decreases, down 37% overall to 165K.
- Monthly visits
- 165,226
- Month over month
- -19.6%
- 3-month change
- -37.5%
- Global rank
- 252,232
LinkedIn
Guided by our Mission to deliver the greatest possible impact to people through mRNA medicines, Moderna remained focused in 2025 on operational execution...
Guided by our Mission to deliver the greatest possible impact to people through mRNA medicines, Moderna remained focused in 2025 on operational execution, scientific progress and disciplined financial management - navigating a difficult environment while strengthening our foundation for long-term growth. With three...
- Likes
- 145
- Comments
- 7
- Tags
- Corporate Strategy, Product Development, Investor Relations, Manufacturing Operations
Showing 10 of 57+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Moderna with the Signal API
One POST /v1/companies/enrich call with modernatx.com returns Moderna signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "modernatx.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Moderna other signals
What signals does Autobound track for Moderna besides news and filings?
What are people saying about Moderna online?
What do employees say about working at Moderna?
Has Moderna been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .